Magic Pharmaceutical (600613.SH) released its 2023 annual performance report. The company achieved operating income of 2 during the reporting period...
According to Zhitong Finance App News, Magic Pharmaceutical (600613.SH) released its 2023 annual performance report. During the reporting period, the company achieved operating income of 2,341 billion yuan, a year-on-year decrease of 2%; net profit attributable to shareholders of listed companies was 57.007 million yuan, an increase of 17.41% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 49.104 million yuan, an increase of 0.84% year on year; basic income per share was 0.11 yuan. The company plans to distribute a cash dividend of 1 yuan (tax included) to all shareholders for every 10 shares.